- Home
- PBHC vs ANVS Comparison
PBHC vs ANVS Comparison
Compare PBHC & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBHC
- ANVS
- Stock Information
- Founded
- PBHC 1859
- ANVS 2008
- Country
- PBHC United States
- ANVS United States
- Employees
- PBHC N/A
- ANVS N/A
- Industry
- PBHC Major Banks
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- PBHC Finance
- ANVS Health Care
- Exchange
- PBHC Nasdaq
- ANVS Nasdaq
- Market Cap
- PBHC 108.9M
- ANVS 92.6M
- IPO Year
- PBHC N/A
- ANVS 2020
- Fundamental
- Price
- PBHC $17.61
- ANVS $4.37
- Analyst Decision
- PBHC
- ANVS Strong Buy
- Analyst Count
- PBHC 0
- ANVS 6
- Target Price
- PBHC N/A
- ANVS $29.67
- AVG Volume (30 Days)
- PBHC 4.5K
- ANVS 322.4K
- Earning Date
- PBHC 01-30-2025
- ANVS 11-08-2024
- Dividend Yield
- PBHC 2.27%
- ANVS N/A
- EPS Growth
- PBHC N/A
- ANVS N/A
- EPS
- PBHC 0.25
- ANVS N/A
- Revenue
- PBHC $35,494,000.00
- ANVS N/A
- Revenue This Year
- PBHC N/A
- ANVS N/A
- Revenue Next Year
- PBHC N/A
- ANVS N/A
- P/E Ratio
- PBHC $70.35
- ANVS N/A
- Revenue Growth
- PBHC N/A
- ANVS N/A
- 52 Week Low
- PBHC $11.41
- ANVS $4.31
- 52 Week High
- PBHC $19.86
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- PBHC 52.03
- ANVS 26.09
- Support Level
- PBHC $16.81
- ANVS $5.24
- Resistance Level
- PBHC $17.92
- ANVS $5.21
- Average True Range (ATR)
- PBHC 0.51
- ANVS 0.51
- MACD
- PBHC -0.03
- ANVS -0.10
- Stochastic Oscillator
- PBHC 82.87
- ANVS 1.89
About PBHC Pathfinder Bancorp Inc. (MD)
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.